Acute Acalculous Cholecystitis in Critical Illness: A Comprehensive Review

Abstract

Acute acalculous cholecystitis (AAC) is a severe inflammatory condition of the gallbladder, predominantly occurring in critically ill patients without evidence of gallstones. This review synthesizes current scientific evidence and guideline-based recommendations on AAC, emphasizing epidemiology, pathophysiology, risk factors, clinical features, diagnosis, management, and recent advances. The article provides clinicians with up-to-date insights into the recognition and optimal treatment of AAC in the context of critical illness, aiming to enhance patient outcomes through early diagnosis and evidence-driven interventions.

Introduction

AAC represents a life-threatening entity that differs from calculous cholecystitis by the absence of gallstones and its predilection for critically ill or postoperative patients. Despite being less common than the calculous form, AAC carries significant morbidity and mortality, largely owing to diagnostic delays and the complex clinical context in which it arises. Understanding the nuances of AAC is essential for intensivists, surgeons, and other healthcare professionals managing high-risk populations in intensive care units (ICUs) and hospital settings.

Epidemiology / Disease Burden

AAC accounts for approximately 5-10% of all cases of acute cholecystitis, but its prevalence escalates dramatically in critically ill cohorts, comprising up to 50-70% of cholecystitis cases in this subgroup. The incidence is particularly elevated in patients with multiple comorbidities, those undergoing major surgery, trauma, burns, or sepsis. The mortality associated with AAC ranges between 30-50%, a figure markedly higher than its calculous counterpart, reflecting underlying patient vulnerability and the aggressive nature of the disease.

Pathophysiology

The pathogenesis of AAC is multifactorial, with gallbladder stasis and ischemia playing central roles. Prolonged fasting, total parenteral nutrition, and reduced enteral stimulation diminish gallbladder contractility, leading to bile stasis and subsequent inflammation. Ischemic injury results from hypotension, vasopressor use, and microvascular thrombosis, which compromise gallbladder perfusion. Superimposed infection may ensue due to bacterial translocation or secondary to local inflammation. The interplay of these mechanisms culminates in gallbladder wall necrosis, gangrene, and, if unaddressed, perforation.

Risk Factors

Risk factors for AAC predominantly reflect the severity of underlying illness. Key contributors include prolonged mechanical ventilation, shock, major trauma, sepsis, extensive burns, and recent major surgery. Other contributors comprise parenteral nutrition, immunosuppression, diabetes mellitus, and advanced age. The administration of opioids, which impair biliary motility, and use of vasopressors, which exacerbate splanchnic hypoperfusion, further increase susceptibility in ICU settings.

Clinical Features

Clinical presentation of AAC is often subtle or atypical in critically ill patients, complicating timely diagnosis. Classical right upper quadrant pain and Murphy's sign may be absent or masked due to sedation, mechanical ventilation, or altered sensorium. Fever, leukocytosis, and unexplained sepsis are common but nonspecific findings. Other features may include jaundice, ileus, and signs of peritonitis in advanced cases. The non-specific symptomatology necessitates a high index of suspicion in high-risk patients with unexplained clinical deterioration.

Diagnosis

Early diagnosis is paramount, yet challenging. Laboratory findings are non-specific, typically revealing leukocytosis and mildly elevated liver enzymes. Imaging is central to diagnosis, with ultrasound being the initial modality of choice. Sonographic features include gallbladder wall thickening (>3 mm), pericholecystic fluid, and a distended gallbladder without stones. The absence of gallstones is a defining criterion. Computed tomography (CT) offers superior delineation of complications such as gangrene or perforation. Hepatobiliary iminodiacetic acid (HIDA) scanning may aid in equivocal cases, demonstrating non-visualization of the gallbladder. Diagnostic paracentesis of pericholecystic fluid for microbiological analysis can provide additional information.

Treatment & Management

Management of AAC necessitates a multidisciplinary approach. Initial steps include hemodynamic stabilization, broad-spectrum intravenous antibiotics targeting gram-negative and anaerobic organisms, and supportive care. Cholecystectomy remains the definitive therapy; however, many critically ill patients are high-risk surgical candidates. In such cases, percutaneous cholecystostomy under radiologic guidance is a validated, minimally invasive alternative, offering both diagnostic and therapeutic benefits. Delayed surgical intervention may be considered once the patient stabilizes. Prompt intervention is essential to mitigate progression to gangrene or perforation, both associated with sharply increased mortality.

Recent Advances / Emerging Therapies

Advances in critical care and interventional radiology have improved AAC outcomes. Enhanced imaging modalities, including contrast-enhanced ultrasound and magnetic resonance imaging (MRI), facilitate earlier and more accurate diagnosis. The role of percutaneous cholecystostomy has expanded, with studies showing favorable outcomes in high-risk populations. Endoscopic ultrasound-guided gallbladder drainage is an evolving technique offering potential benefits in select patients. Ongoing research explores the utility of biomarkers and the role of antimicrobial stewardship to optimize therapy and reduce complications.

Guideline Recommendations

Recent guidelines from surgical and critical care societies advocate for early consideration of AAC in critically ill patients with unexplained fever or sepsis. Bedside ultrasound is recommended as the initial diagnostic modality, with CT or MRI as adjuncts in complex cases. Empiric broad-spectrum antibiotics should be initiated promptly. Cholecystectomy is preferred in operable patients, whereas percutaneous cholecystostomy is endorsed for those who are poor surgical candidates. Repeat imaging and clinical reassessment guide the timing of definitive surgery. Multidisciplinary collaboration is emphasized to tailor treatment to individual risk profiles and optimize outcomes.

Conclusion

AAC is a formidable complication in the critically ill, demanding vigilance and swift intervention. Its subtle presentation and rapid progression underscore the need for heightened clinical suspicion, timely imaging, and evidence-based management. Advances in diagnostic and interventional modalities offer new avenues for improved outcomes. Adhering to guideline recommendations and fostering interdisciplinary collaboration remain essential in reducing morbidity and mortality associated with AAC in critical illness.